Transfection of v-rasHDNA into MCF-7 human breast cancer cells bypasses dependence on estrogen for tumorigenicity

Attan Kasid, Marc E. Lippman, Alex G. Papageorge, Douglas R. Lowy, Edward P. Gelmann

Research output: Contribution to journalArticlepeer-review

149 Scopus citations

Abstract

The natural history of estrogen-responsive breast cancers often involves a phenotypic change to an estrogen-unresponsive, more aggressive tumor. The human breast cancer cell line, MCF-7, which requires estradiol for tumor formation in vivo and shows growth stimulation in response to estradiol in vitro, is a model for hormone-responsive tumors. The v-rasH onc gene was transfected into MCF-7 cells. The cloned MCF-7ras transfectants, which expressed the v-rasH messenger RNA and v-rasH p21 protein (21,000 daltons), were characterized. In contrast to the parental cell line, MCF-7 ras cells no longer responded to exogenous estrogen in culture and their growth was minimally inhibited by exogenous antiestrogens. When tested in the nude mouse, the MCF-7ras cells were fully tumorigenic in the absence of estrogen supplementation. Thus, cells acquiring an activated one gene can bypass the hormonal regulatory signals that trigger the neoplastic growth of a human breast cancer cell line.

Original languageEnglish (US)
Pages (from-to)725-728
Number of pages4
JournalScience
Volume228
Issue number4700
DOIs
StatePublished - 1985
Externally publishedYes

ASJC Scopus subject areas

  • General

Fingerprint

Dive into the research topics of 'Transfection of v-rasHDNA into MCF-7 human breast cancer cells bypasses dependence on estrogen for tumorigenicity'. Together they form a unique fingerprint.

Cite this